Blood Research

Cited by CrossRef (14)

  1. Carolina Caserta, Silvia Nucera, Matteo Barcella, Grazia Fazio, Matteo Maria Naldini, Riccardo Pagani, Francesca Pavesi, Giacomo Desantis, Erika Zonari, Mariella D’Angiò, Paola Capasso, Angelo Lombardo, Ivan Merelli, Orietta Spinelli, Alessandro Rambaldi, Fabio Ciceri, Daniela Silvestri, Maria Grazia Valsecchi, Andrea Biondi, Giovanni Cazzaniga, Bernhard Gentner. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease. Leukemia 2023;37:1994
    https://doi.org/10.1038/s41375-023-02009-5
  2. RashaAbd-El-Rahman El-Gamal, MonaAhmed Ismail, InasAbdelmoaty Mohamed, MervatAbdalhameed Alfeky. Individualized antigen expression in precursor T-cell acute lymphoblastic leukemia: A gate to minimal residual disease analysis by flow cytometry. J Appl Hematol 2022;13:268
    https://doi.org/10.4103/joah.joah_128_21
  3. Thai Hoa Tran, Stephen P. Hunger. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities. Seminars in Cancer Biology 2022;84:144
    https://doi.org/10.1016/j.semcancer.2020.10.013
  4. Caner Saygin,, Sarah Monick, Wendy Stock. Cancer Consult. 2022.
    https://doi.org/10.1002/9781119823193.ch4
  5. Zuzanna Urbańska, Monika Lejman, Joanna Taha, Joanna Madzio, Kinga Ostrowska, Karolina Miarka-Walczyk, Kamila Wypyszczak, Borys Styka, Justyna Jakubowska, Łukasz Sędek, Tomasz Szczepański, Marcin Stańczak, Wojciech Fendler, Wojciech Młynarski, Agata Pastorczak. The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia. Neoplasia 2023;35:100840
    https://doi.org/10.1016/j.neo.2022.100840
  6. Marcin Braun, Agata Pastorczak, Łukasz Sędek, Joanna Taha, Joanna Madzio, Izabela Jatczak‐Pawlik, Kamila Wypyszczak, Michał Matysiak, Katarzyna Derwich, Monika Lejman, Bernarda Kazanowska, Tomasz Szczepański, Jerzy R. Kowalczyk, Wojciech Mlynarski. Prognostic significance of IKZF1 deletions and IKZF1plus profile in children with B‐cell precursor acute lymphoblastic leukemia treated according to the ALL‐IC BFM 2009 protocol. Hematological Oncology 2022;40:430
    https://doi.org/10.1002/hon.2973
  7. Wei Zhang, Jia Ju, Yong Zhou, Teng Xiong, Mengyao Wang, Chaohui Li, Shixin Lu, Zefeng Lu, Liya Lin, Xiao Liu, Shuai Cheng Li. IMperm: a fast and comprehensive IMmune Paired-End Reads Merger for sequencing data. 2023;24
    https://doi.org/10.1093/bib/bbad080
  8. Xiaohui Zhang. Practical Oncologic Molecular Pathology. 2023.
    https://doi.org/10.1007/978-3-030-73227-1_15
  9. Alexandra Neaga, Laura Jimbu, Oana Mesaros, Madalina Bota, Diana Lazar, Simona Cainap, Cristina Blag, Mihnea Zdrenghea. Why Do Children with Acute Lymphoblastic Leukemia Fare Better Than Adults?. Cancers 2021;13:3886
    https://doi.org/10.3390/cancers13153886
  10. Cristina Tecchio, Anna Russignan, Mauro Krampera. Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1047554
  11. Özlem Tüfekçi, Melike Sezgin Evim, Adalet Meral Güneş, Tiraje Celkan, Deniz Yilmaz Karapinar, Zühre Kaya, Birsen Baysal, Birol Baytan, Ülker Koçak, Şebnem Yilmaz, Suzan Çinar, Hale Ören. Assessment of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: A Multicenter Study From Turkey. 2022;44:e396
    https://doi.org/10.1097/MPH.0000000000002419
  12. Haipin Chen, Miner Gu, Juan Liang, Hua Song, Jingying Zhang, Weiqun Xu, Fenying Zhao, Diying Shen, Heping Shen, Chan Liao, Yongmin Tang, Xiaojun Xu. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL. Nat Commun 2023;14
    https://doi.org/10.1038/s41467-023-43171-9
  13. Miyoung Kim, Chan-Jeoung Park. Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia. Clin Pediatr Hematol Oncol 2020;27:87
    https://doi.org/10.15264/cpho.2020.27.2.87
  14. Juan Carlos Núñez-Enríquez, Rubí Romo-Rodríguez, Pedro Gaspar-Mendoza, Gabriela Zamora-Herrera, Lizeth Torres-Pineda, Jiovanni Amador-Cardoso, Jebea A. López-Blanco, Laura Alfaro-Hernández, Lucero López-García, Arely Rosas-Cruz, Dulce Rosario Alberto-Aguilar, César Omar Trejo-Pichardo, Dalia Ramírez-Ramírez, Astin Cruz-Maza, Janet Flores-Lujano, Nuria Luna-Silva, Angélica Martínez-Martell, Karina Martínez-Jose, Anabel Ramírez-Ramírez, Juan Carlos Solis-Poblano, Patricia Zagoya-Martínez, Vanessa Terán-Cerqueda, Andrea Huerta-Moreno, Álvaro Montiel-Jarquín, Miguel Garrido-Hernández, Raquel Hernández-Ramos, Daniela Olvera-Caraza, Cynthia Shanat Cruz-Medina, Enoch Alvarez-Rodríguez, Lénica Anahí Chávez-Aguilar, Wilfrido Herrera-Olivares, Brianda García-Hidalgo, Lena Sarahí Cano-Cuapio, Claudia Guevara-Espejel, Gerardo Juárez-Avendaño, Juan Carlos Balandrán, Ma. del Rocío Baños-Lara, Mariana Cárdenas-González, Elena R. Álvarez-Buylla, Sonia Mayra Pérez-Tapia, Diana Casique-Aguirre, Rosana Pelayo. Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1304690
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd